Cybin Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
CYBN NYSE American 2834 www.cybin.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cybin Inc.

Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024 - Oct 3rd, 2024 11:30 am
Cybin Expands Clinical Team to Support CYB003 Phase 3 Program - Oct 1st, 2024 11:30 am
Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit - Sep 24th, 2024 11:30 am
Cybin Provides Corporate Update on Upcoming Clinical Milestones - Sep 19th, 2024 9:38 pm
Cybin Announces Completion of Previously Announced Share Consolidation - Sep 19th, 2024 11:26 am
Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Sep 4th, 2024 11:55 am
Cybin Announces Results of Annual and Special Meeting of Shareholders and Share Consolidation - Aug 27th, 2024 11:01 pm
Cybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive Disorder - Aug 13th, 2024 11:30 am
Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights - Aug 8th, 2024 11:36 am
Cybin to Participate in the Canaccord Genuity 44th Annual Growth Conference - Aug 7th, 2024 11:30 am
A Swell Of Insider Purchases Follow Cybin Inc.'s Positive Year-End Update - Jul 8th, 2024 12:38 pm
What Makes Cybin Inc. (CYBN) a New Buy Stock - Jun 27th, 2024 4:00 pm
Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights - Jun 26th, 2024 11:41 am
Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - Jun 19th, 2024 11:30 am
Down -17.45% in 4 Weeks, Here's Why Cybin Inc. (CYBN) Looks Ripe for a Turnaround - Jun 11th, 2024 1:35 pm
Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical Development - Jun 11th, 2024 11:30 am
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024 - May 29th, 2024 11:30 am
Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase - May 14th, 2024 11:30 am
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones - May 6th, 2024 12:32 pm
Cybin to Participate at the 27th Annual Milken Institute Global Conference - Apr 25th, 2024 11:30 am